Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
CNS Neurol Disord Drug Targets ; 16(7): 772-780, 2017.
Artículo en Inglés | MEDLINE | ID: mdl-28124605

RESUMEN

BACKGROUND: Epilepsy is one of the most common neurological disorders in humans, and the role of the cerebellum in its physiopathology remains the subject of study. The Purkinje cells (PC), whose axons target the dentate and interpositus nuclei, form the main cerebellar output to forebrain structures involved in epilepsy. Cerebellar atrophy related to loss of PC has been reported in chronic epilepsy although its mechanism remains unclear. Taking into account that an overexpression of ß-Catenin has been related with cell death, here we present the signaling of ß-Catenin and the type of PC death in cerebellum of rats with seizures induced by the amygdaloid kindling model. METHOD: Using an immunohistochemistry and western blot assay for ß-Catenin, c-Myc, cyclin D3, TUNEL and caspase-3, in rats chronically implanted with electrodes, receiving 0, 3, 15, and 45 electrical stimuli. RESULTS: We found that such rats suffering a major number of stimuli showed the highest amount of marks assessed. CONCLUSION: We concluded that there is a higher activity of the Wnt/ß-Catenin pathway associated with increased number of stimuli may be related with the presence of apoptosis in the cerebellum treated with amygdala kindling. In this way, we suggest this pathway as one of the mechanisms by which cerebellar neurons death in generalized seizures.


Asunto(s)
Apoptosis/fisiología , Cerebelo/fisiopatología , Excitación Neurológica/fisiología , Vía de Señalización Wnt/fisiología , beta Catenina/metabolismo , Animales , Caspasa 3/metabolismo , Cerebelo/metabolismo , Cerebelo/fisiología , Ciclina D3/metabolismo , Estimulación Eléctrica , Electrodos Implantados , Excitación Neurológica/metabolismo , Proteínas Proto-Oncogénicas c-myc/metabolismo , Células de Purkinje/metabolismo , Ratas , Convulsiones/metabolismo
2.
CNS Neurol Disord Drug Targets ; 15(6): 723-9, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-26996170

RESUMEN

The single feature of all malformations in cortical development is the clinical association with epilepsy. It has been proven that Sox-1 expression is essential during neurodevelopment and it is reported that Sox-1 knockout mice present spontaneous generalized seizures. Particularly in cerebellum, Sox-1 plays a key role in the Bergmann´s glia (BG) function, which allows the correct function of the Purkinje cells (PC). The targets of PC are the dentate and interpositus nuclei, which form the main cerebellar efferents involved in the physiopathology of epilepsy. Here we present the Sox-1 expression in cerebellum of rats during electric amygdala-kindling. We obtained seizures and once they had 3, 15 and 45 electric stimuli, the animals were sacrificed; the cerebellum was processed for inmunohistochemistry and Western blot analysis was performed to determine Sox-1 expression. Liquid chromatography was performed to examine gammaaminobutyric acid (GABA) and glutamate concentration. According to the literature, a progressive increase was observed in the electrographic and behavioral parameters. We found that Sox-1 expression in 15 and 45-stimuli groups had a statistically significant decrease as compared with controls, while the 3-stimuli group was similar to the control group. The concentration of glutamate was increased in rats with 45 stimuli. We can conclude that Sox-1 expression decreases as the number of seizures increases, and this is probably due to an altered glutamate regulation by a dysfunctional BG. In this way, we can suggest this mechanism as a one possible explanation of how the cerebellum participates in the pathophysiology of epilepsy.


Asunto(s)
Cerebelo/metabolismo , Epilepsia Generalizada/metabolismo , Factores de Transcripción SOXB1/metabolismo , Convulsiones/metabolismo , Amígdala del Cerebelo/metabolismo , Amígdala del Cerebelo/patología , Animales , Western Blotting , Cerebelo/patología , Cromatografía Líquida de Alta Presión , Modelos Animales de Enfermedad , Progresión de la Enfermedad , Estimulación Eléctrica , Epilepsia Generalizada/patología , Ácido Glutámico/metabolismo , Inmunohistoquímica , Excitación Neurológica/metabolismo , Excitación Neurológica/patología , Neuroglía/metabolismo , Neuroglía/patología , Ratas Wistar , Subunidad beta de la Proteína de Unión al Calcio S100/metabolismo , Convulsiones/patología , Ácido gamma-Aminobutírico/metabolismo
3.
Eur J Pharmacol ; 627(1-3): 185-93, 2010 Feb 10.
Artículo en Inglés | MEDLINE | ID: mdl-19857485

RESUMEN

Peroxisome proliferator activated receptors (PPARs) are a family of nuclear receptors that, upon activation with selective ligands, work as transcription factors. Recently, these have been related with the cardiovascular system. Our aim was to study PPARalpha-stimulation and its effects on blood pressure in rats with aortic coarctation, and to explore the role of the antioxidant system. Male Wistar rats (250-280 g) were distributed into the following groups: 1) sham; 2) aortic coarctated-vehicle-treated (AoCo-V), and 3) AoCo-clofibrate (100mg/kg) treated (AoCo-C). Rats were treated for 1 or 21 days. Clofibrate lowered blood pressure in both 1- and 21-day treatments. Renal reactive oxygen species increased after 1 day in AoCo-V, while clofibrate prevented this effect. Superoxide dismutase (SOD)-1 expression increased 3.6-fold upon PPARalpha stimulation (1 day) and returned to normal values by day 21. SOD-1 activity increased slightly in response to clofibrate. Renal activity of catalase increased in AoCo-C (1 day) and returned to normal (21 days). eNOS expression was not modified acutely (1 day) but increased at 21 days of treatment with clofibrate. Angiotensin II AT(1)-receptor expression as well as angiotensin II decreased in clofibrate-treated rats, while angiotensin II AT(2)-receptor expression increased, in both treatment periods. Angiotensin-(1-7) increased at 21 days. Our results suggest that in the early development of AoCo-induced hypertension, stimulation of PPARalpha increases the antioxidant defenses, leading to improvement in endothelial factors while in the sub-chronic phase (21 days), eNOS and angiotensin II receptors appear to play major roles in controlling blood pressure.


Asunto(s)
Presión Sanguínea , PPAR alfa/metabolismo , Angiotensina II/metabolismo , Animales , Antioxidantes/farmacología , Coartación Aórtica/complicaciones , Presión Sanguínea/efectos de los fármacos , Clofibrato/administración & dosificación , Clofibrato/farmacología , Regulación de la Expresión Génica/efectos de los fármacos , Hipertensión/etiología , Hipertensión/metabolismo , Hipertensión/fisiopatología , Peroxidación de Lípido/efectos de los fármacos , Masculino , Óxido Nítrico Sintasa de Tipo III/metabolismo , Oxidorreductasas/metabolismo , Ratas , Ratas Wistar , Especies Reactivas de Oxígeno/metabolismo , Receptores de Angiotensina/metabolismo , Superóxido Dismutasa/metabolismo , Factores de Tiempo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...